Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells

被引:3
|
作者
Rosado-Galindo, Heizel [1 ]
Domenech, Maribella [1 ,2 ]
机构
[1] Univ Puerto Rico Mayaguez, Bioengn Program, Mayaguez, PR 00682 USA
[2] Univ Puerto Rico Mayaguez, Dept Chem Engn, Mayaguez, PR 00682 USA
基金
美国国家卫生研究院;
关键词
topography; EGFR signaling; TNBC; secretome; stemness; PHASE-II; TARGETED THERAPY; GROWTH; PROLIFERATION; RESISTANCE; PROMOTES; OVEREXPRESSION; CHALLENGES; SIGNATURE; YAP/TAZ;
D O I
10.3389/fcell.2023.1124250
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Cancer stem cells (CSC), a major culprit of drug-resistant phenotypes and tumor relapse, represent less than 2 % of the bulk of TNBC cells, making them difficult to isolate, study, and thus, limiting our understanding of the pathogenesis of the disease. Current methods for CSC enrichment, such as 3D spheroid culture, genetic modification, and stem cell conditioning, are time consuming, expensive, and unsuitable for high-throughput assays. One way to address these limitations is to use topographical stimuli to enhance CSC populations in planar culture. Physical cues in the breast tumor microenvironment can influence cell behavior through changes in the mechanical properties of the extracellular matrix (ECM). In this study, we used topographical cues on polystyrene films to investigate their effect on the proteome and stemness of standard TNBC cell lines.Methods: The topographical polystyrene-based array was generated using razor printing and polishing methods. Proteome data were analyzed and enriched bioprocesses were identified using R software. Stemness was assessed measuring CD44, CD24 and ALDH markers using flow cytometry, immunofluorescence, detection assays, and further validated with mammosphere assay. EGF/EGFR expression and activity was evaluated using enzyme-linked immunosorbent assay (ELISA), immunofluorescence and antibody membrane array. A dose-response assay was performed to further investigate the effect of surface topography on the sensitivity of cells to the EGFR inhibitor.Results: Surface roughness enriched the CSC population and modulated epidermal growth factor receptor (EGFR) signaling activity in TNBC cells. Enhanced proliferation of MDA-MB-468 cells in roughness correlated with upregulation of the epidermal growth factor (EGF) ligand, which in turn corresponded with a 3-fold increase in the expression of EGFR and a 42% increase in its phosphorylation compared to standard smooth culture surfaces. The results also demonstrated that phenotypic changes associated with topographical (roughness) stimuli significantly decreased the drug sensitivity to the EGFR inhibitor gefitinib. In addition, the proportion of CD44+/CD24-/ALDH+ was enhanced on surface roughness in both MDA-MB-231 and MDA-MB-468 cell lines. We also demonstrated that YAP/TAZ activation decreased in a roughness-dependent manner, confirming the mechanosensing effect of the topographies on the oncogenic activity of the cells.Discussion: Overall, this study demonstrates the potential of surface roughness as a culture strategy to influence oncogenic activity in TNBC cells and enrich CSC populations in planar cultures. Such a culture strategy may benefit high-throughput screening studies seeking to identify compounds with broader tumor efficacy.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
    Ferraro, Daniela A.
    Gaborit, Nadege
    Maron, Ruth
    Cohen-Dvashi, Hades
    Porat, Ziv
    Pareja, Fresia
    Lavi, Sara
    Lindzen, Moshit
    Ben-Chetrit, Nir
    Sela, Michael
    Yarden, Yosef
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (05) : 1815 - 1820
  • [22] Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple-negative breast cancer cells
    Wu, Jinna
    Li, Jia
    Xu, Huiya
    Qiu, Ni
    Huang, Xiaojia
    Li, Hongsheng
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [23] Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
    Jiang, Weihua
    Wang, Xiaowen
    Zhang, Chenguang
    Xue, Laiti
    Yang, Liang
    ONCOLOGY LETTERS, 2020, 19 (03) : 1842 - 1848
  • [24] Triple-Negative Breast Cancer
    Winkeljohn, Debra L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (06) : 861 - 863
  • [25] Triple-Negative Breast Cancer
    Hudis, Clifford A.
    CANCER JOURNAL, 2010, 16 (01): : 10 - 11
  • [26] Triple-Negative Breast Cancer
    Quyen D. Chu
    King, Tari
    Hurd, Thelma
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
  • [27] Triple-negative breast cancer
    Chacon, Reinaldo D.
    Costanzo, Maria V.
    BREAST CANCER RESEARCH, 2010, 12
  • [28] Triple-negative breast cancer
    Stockmans, Gert
    Deraedt, Karen
    Wildiers, Hans
    Moerman, Philippe
    Paridaens, Robert
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 614 - 620
  • [29] Triple-Negative Breast Cancer
    Foulkes, William D.
    Smith, Ian E.
    Reis-Filho, Jorge S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20): : 1938 - 1948
  • [30] Triple-negative breast cancer
    Bartsch R.
    Ziebermayr R.
    Zielinski C.C.
    Steger G.G.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 174 - 181